Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Furan Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1989148A reveals a solid-state synthesis route for 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose, enabling scalable Gemcitabine production with superior purity.
Patent CN104059036B enables high-yield synthesis of Ranitidine intermediate. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102276559A details a cost-effective gamma-butyrolactone route for 3-hydroxymethyltetrahydrofuran, offering high purity and scalable production for dinotefuran manufacturing.
Novel maleic diester route for 3-aminomethyltetrahydrofuran. High yield, low cost, scalable process for dinotefuran intermediates.
Novel synthesis method for TAK-875 intermediate ensuring high purity and scalable production for global pharmaceutical supply chains.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Patent CN107089957B reveals efficient one-step synthesis. Offers cost reduction and scalable supply for global fragrance and pharma intermediate manufacturers seeking reliability.
Novel two-step synthesis for Amiodarone intermediate improves yield and reduces cost. Reliable supply chain solution for pharmaceutical manufacturing.
Novel ruthenium-catalyzed route for Prucalopride intermediate offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without toxic osmium reagents.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN115043799A reveals a novel BF3-catalyzed route for 5,6-dihydrobenzofuranone derivatives, offering high atom economy and simplified supply chains for pharmaceutical manufacturing.
Patent CN120230062A details a novel copper-catalyzed route for (R)-4-propyl-dihydrofuran-2-one, offering improved yield and supply chain reliability for pharmaceutical manufacturers.
Patent CN105384710A reveals a novel Ru-Sc synergistic catalytic method for furan intermediates. Achieves high purity and yield with simplified post-processing for scalable supply.
Novel Heck reaction synthesis for Ramelteon intermediate offers high yield and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN105384710B reveals a high-yield furan synthesis method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN109553595B reveals a cost-effective route to (R)-4-propyl-4,5-dihydrofuran-2(3H)-one using mild weak-base conditions and cheap diol starting materials.
Novel one-step synthesis of benzofuran-3-carboxamides using Pd-catalyzed carbonylation. Offers high efficiency and substrate compatibility for pharmaceutical intermediates.